Re­pub­li­can sen­a­tors join at­tack on Biden's pro­pos­al to seize drug patents based on price

As Pres­i­dent Joe Biden con­tin­ues to tout his ad­min­is­tra­tion’s ef­forts to low­er drug prices, 16 Re­pub­li­can sen­a­tors on Mon­day raised con­cerns with NIH di­rec­tor Mon­i­ca Bertag­nol­li over plans to “march-in” and seize phar­ma com­pa­ny patents if the price of a drug is too high.

Led by Sen. Bill Cas­sidy (R-LA), the rank­ing mem­ber of the Sen­ate Com­mit­tee on Health, Ed­u­ca­tion, La­bor and Pen­sions, the let­ter ar­gued that no fed­er­al agency has ever used the Bayh-Dole Act to do what Biden wants, and that the NIH has re­ject­ed sim­i­lar re­quests un­der the law.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER